Premium
De‐Iron: a phase 2 trial of the activity and safety of Deferasirox administered at early iron loading in patients with transfusion‐dependent myelodysplastic syndromes
Author(s) -
Killick Sally,
Jackson Aimee,
Coulthard Helen C.,
Yap Christina,
DasGupta Emma,
Pennell Dudley J.,
Porter John,
Bowen David,
Culligan Dominic
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16669
Subject(s) - deferasirox , hematology , medicine , myelodysplastic syndromes , clinical trial , intensive care medicine , thalassemia , bone marrow
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom